Form 4: Charles River Laboratories Executive Boosts Stake with Restricted Stock Unit Grant

Michael G. Knell, CSVP & Chief Accounting Officer at Charles River Laboratories, reported the acquisition of 2,064 shares of common stock, increasing his beneficial ownership to 10,534 shares after tax-related disposals.

Summary

• Michael G. Knell, CSVP & Chief Accounting Officer of Charles River Laboratories International, Inc. (CRL), acquired 2,064 shares of common stock on May 30, 2025, at a price of $135.63 per share.
• These shares are unvested restricted stock units (RSUs) that will vest annually on May 30, 2026, 2027, 2028, and 2029.
• Following the acquisition, Mr. Knell disposed of 48 shares on May 31, 2025, and 225 shares on June 1, 2025, both at $135.63 per share, likely for tax withholding purposes related to the RSU grant.
• After these transactions, Mr. Knell's direct beneficial ownership of Charles River Laboratories common stock stands at 10,534 shares.

Sentiment

Score: 7

Explanation: The document reports a routine insider transaction involving the grant of restricted stock units and subsequent tax-related disposals. The net effect is an increase in the executive's beneficial ownership, which is generally viewed positively as it aligns management interests with shareholders. There are no negative surprises or significant risks disclosed.

Positives

• The acquisition of 2,064 shares by a key executive, Michael G. Knell, aligns management's interests with shareholders, indicating confidence in the company's future.
• The grant of restricted stock units is a common form of long-term incentive compensation, designed to retain key talent and encourage long-term performance.

Future Outlook

The vesting schedule for the restricted stock units extends through May 30, 2029, indicating a long-term incentive structure for the executive.

Industry Context

This transaction is a routine executive compensation event within the life sciences and pharmaceutical services industry, where stock-based incentives are common to align executive and shareholder interests.

Stakeholder Impact

• Shareholders: The increase in executive ownership through stock grants can be seen as a positive signal of management's commitment and alignment with shareholder value.
• Employees: The grant of restricted stock units is part of the company's executive compensation strategy, which can influence overall employee morale and retention efforts.

Next Steps

• Future vesting of the acquired restricted stock units will occur annually on May 30, 2026, 2027, 2028, and 2029.
• Subsequent Form 4 filings will be required for any further changes in beneficial ownership by Michael G. Knell.

Key Dates

Keywords

Charles River Laboratories, CRL, SEC Form 4, Insider Trading, Stock Acquisition, Restricted Stock Units, Executive Compensation, Michael Knell, Beneficial Ownership